bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 19, 2025
Transcranial
ultrasonic
stimulation
(TUS)
redefines
what
is
possible
with
non-invasive
neuromodulation
by
oaering
unparalleled
spatial
precision
and
flexible
targeting
capabilities.
However,
peripheral
confounds
pose
a
significant
challenge
to
reliably
implementing
this
technology.
While
auditory
during
TUS
have
been
studied
extensively,
the
somatosensory
confound
has
overlooked
thus
far.
It
will
become
increasingly
vital
quantify
manage
as
field
shifts
towards
higher
doses,
more
compact
devices,
frequent
through
temple
where
co-stimulation
pronounced.
Here,
we
provide
systematic
characterisation
of
TUS.
We
also
identify
conditions
under
which
can
be
mitigated
most
eaectively
mapping
confound-parameter
space.
Specifically,
investigate
dose-response
eaects,
pulse
shaping
characteristics,
transducer-specific
parameters.
demonstrate
that
avoiding
near-field
intensity
peaks
in
scalp,
spreading
energy
across
greater
area
ramping
envelope,
delivering
equivalent
doses
via
longer,
lower-intensity
pulses
rather
than
shorter,
higher-intensity
pulses.
Additionally,
repetition
frequencies
fundamental
reduce
eaects.
Through
our
parameter
space,
find
preliminary
evidence
particle
displacement
(strain)
may
primary
biophysical
driving
force
behind
co-stimulation.
This
study
provides
actionable
strategies
minimise
confounds,
support
thorough
experimental
control
required
unlock
full
potential
for
scientific
research
clinical
interventions.
Tactile,
thermal,
even
painful
occur
TUS.Confounds
&
parameters.Valid
replicable
requires
confounds.Particle
confounds.
Science,
Journal Year:
2024,
Volume and Issue:
385(6714)
Published: Sept. 12, 2024
Focused
ultrasound
is
a
platform
technology
capable
of
eliciting
wide
range
biological
responses
with
high
spatial
precision
deep
within
the
body.
Although
focused
already
in
clinical
use
for
focal
thermal
ablation
tissue,
there
has
been
recent
growth
development
and
translation
ultrasound-mediated
nonthermal
therapies.
These
approaches
exploit
physical
forces
to
produce
dependent
on
exposure
conditions.
This
review
discusses
advances
four
application
areas
that
have
seen
particular
immense
potential:
brain
drug
delivery,
neuromodulation,
tissue
destruction,
endogenous
immune
system
activation.
Owing
maturation
transcranial
technology,
major
target
organ;
however,
indications
outside
are
also
discussed.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 13, 2024
Abstract
Ultrasound
is
an
acoustic
wave
which
can
noninvasively
penetrate
the
skull
to
deep
brain
regions,
enabling
neuromodulation.
However,
conventional
ultrasound’s
spatial
resolution
diffraction-limited
and
low-precision.
Here,
we
report
nanobubble-mediated
ultrasound
stimulation
capable
of
localizing
effects
only
desired
region
in
male
mice.
By
varying
delivery
site
nanobubbles,
could
activate
specific
regions
mouse
motor
cortex,
evoking
EMG
signaling
limb
movement,
also,
separately,
one
two
nearby
elicit
distinct
behaviors
(freezing
or
rotation).
Sonicated
neurons
displayed
reversible,
low-latency
calcium
responses
increased
c-Fos
expression
sub-millimeter-scale
with
nanobubbles
present.
relevant
also
modified
depression-like
behavior
a
model.
We
provide
evidence
role
for
mechanosensitive
ion
channels.
Altogether,
our
treatment
scheme
allows
spatially-targetable,
repeatable
temporally-precise
activation
circuits
neuromodulation
without
needing
genetic
modification.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(13)
Published: Jan. 10, 2024
Abstract
Ultrasound
technology,
synergistically
harnessed
with
genetic
engineering
and
chemistry
concepts,
has
started
to
open
the
gateway
remarkable
realm
of
sonogenetics—a
pioneering
paradigm
for
remotely
orchestrating
cellular
functions
at
molecular
level.
This
fusion
not
only
enables
precisely
targeted
imaging
therapeutic
interventions,
but
also
advances
our
comprehension
mechanobiology
unparalleled
depths.
Sonogenetic
tools
harness
mechanical
force
within
small
tissue
volumes
while
preserving
integrity
surrounding
physiological
environment,
reaching
depths
up
tens
centimeters
high
spatiotemporal
precision.
These
capabilities
circumvent
inherent
physical
limitations
alternative
in
vivo
control
methods
such
as
optogenetics
magnetogenetics.
In
this
review,
we
first
discuss
mechanosensitive
ion
channels,
most
commonly
utilized
sonogenetic
mediators,
both
mammalian
non‐mammalian
systems.
Subsequently,
provide
a
comprehensive
overview
state‐of‐the‐art
approaches
that
leverage
thermal
or
features
ultrasonic
waves.
Additionally,
explore
strategies
centered
around
design
mechanochemically
reactive
macromolecular
Furthermore,
delve
into
ultrasound
biomolecular
function,
encompassing
utilization
gas
vesicles
acoustic
reporter
genes.
Finally,
shed
light
on
challenges
sonogenetics
present
perspective
future
promising
technology.
Brain stimulation,
Journal Year:
2024,
Volume and Issue:
17(4), P. 734 - 751
Published: June 15, 2024
Low-intensity
transcranial
ultrasound
has
surged
forward
as
a
non-invasive
and
disruptive
tool
for
neuromodulation
with
applications
in
basic
neuroscience
research
the
treatment
of
neurological
psychiatric
conditions.
To
provide
comprehensive
overview
update
preclinical
clinical
low
intensity
emphasize
emerging
role
functional
brain
mapping
to
guide,
better
understand,
predict
responses.
A
systematic
review
was
conducted
by
searching
Web
Science
Scopus
databases
studies
on
neuromodulation,
both
humans
animals.
187
relevant
were
identified
reviewed,
including
116
71
reports
subjects
belonging
diverse
cohorts.
Milestones
are
described
within
an
broader
landscape.
General
neural
readouts
outcome
measures
discussed,
potential
confounds
noted,
use
magnetic
resonance
imaging
is
highlighted.
Ultrasound
emerged
powerful
study
treat
range
conditions
its
combination
various
significantly
advanced
this
platform.
In
particular,
yielded
exciting
inferences
into
advance
our
understanding
function,
neuromodulatory
mechanisms,
ultimately
outcomes.
It
anticipated
that
these
trials
first
many;
focused
ultrasound,
particularly
imaging,
enhance
spectrum
Ageing Research Reviews,
Journal Year:
2023,
Volume and Issue:
90, P. 102026 - 102026
Published: July 31, 2023
Since
the
discovery
of
mechanosensitive
Piezo1
channel
in
2010,
there
has
been
a
significant
amount
research
conducted
to
explore
its
regulatory
role
physiology
and
pathology
various
organ
systems.
Recently,
growing
body
compelling
evidence
emerged
linking
activity
health
disease
central
nervous
system.
However,
exact
mechanisms
underlying
these
associations
remain
inadequately
comprehended.
This
review
systematically
summarizes
current
on
implications
for
system
mechanobiology,
retrospects
results
demonstrating
cell
types
within
system,
including
neural
stem
cells,
neurons,
oligodendrocytes,
microglia,
astrocytes,
brain
endothelial
cells.
Furthermore,
discusses
understanding
involvement
disorders,
such
as
Alzheimer's
disease,
multiple
sclerosis,
glaucoma,
stroke,
glioma.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(14)
Published: Feb. 4, 2024
Abstract
Keloids
are
benign
fibroproliferative
tumors
that
severely
diminish
the
quality
of
life
due
to
discomfort,
dysfunction,
and
disfigurement.
Recently,
ultrasound
technology
as
a
noninvasive
adjuvant
therapy
is
developed
optimize
treatment
protocols.
However,
biophysical
mechanisms
have
not
yet
been
fully
elucidated.
Here,
it
proposed
piezo‐type
mechanosensitive
ion
channel
component
1
(Piezo1)
plays
an
important
role
in
low‐frequency
sonophoresis
(LFS)
induced
mechanical
transduction
pathways
trigger
downstream
cellular
signaling
processes.
It
demonstrated
patient‐derived
primary
keloid
fibroblasts
(PKF),
NIH
3T3,
HFF‐1
cell
migration
inhibited,
PKF
apoptosis
significantly
increased
by
LFS
stimulation.
And
effects
diminished
application
GsMTx‐4,
selective
inhibitor
Piezo1,
knockdown
Piezo1.
More
importantly,
can
be
imitated
Yoda1,
agonist
Piezo1
channels.
Establishing
xenograft
implantation
mouse
model
further
verified
these
results,
decreased
volume
weight
keloids.
Moreover,
blocking
impaired
effectiveness
treatment.
These
results
suggest
inhibits
malignant
characteristics
keloids
activating
channel,
thus
providing
theoretical
basis
for
improving
clinical
Stroke,
Journal Year:
2024,
Volume and Issue:
55(10), P. 2547 - 2557
Published: Aug. 15, 2024
Low-intensity
focused
ultrasound
represents
groundbreaking
medical
advancements,
characterized
by
its
noninvasive
feature,
safety,
precision,
and
broad
neuromodulatory
capabilities.
This
technology
operates
through
mechanisms,
for
example,
acoustic
radiation
force,
cavitation,
thermal
effects.
Notably,
with
the
evolution
of
technology,
neuromodulation
has
been
gradually
applied
in
treating
central
nervous
system
diseases,
especially
stroke.
Furthermore,
burgeoning
research
areas
such
as
sonogenetics
nanotechnology
show
promising
potential.
Despite
benefit
low-intensity
precise
biophysical
mechanism
still
need
further
exploration.
review
discusses
recent
ongoing
developments
neurological
regulation,
covering
underlying
rationale
to
current
utility
challenges
that
impede
development
broader
adoption
this
alternative
therapy.